Minimally invasive versus open radical hysterectomy for early-stage cervical cancer
Official title: Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.
Run by Medical University of Silesia · NCT07120529 · Data updated 2026-11-12
This project tests whether laparoscopic (minimally invasive) radical hysterectomy works as well as open abdominal radical hysterectomy for adult women with early-stage cervical cancer who have negative sentinel lymph nodes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Medical University of Silesia Academic / other |
| Locations | 5 sites (Bialystok and 4 other locations) |
| Status | Recruiting |
| Started | September 15, 2025 |
| Main results expected | September 1, 2030 |
| Study ends | December 1, 2030 |
| Registry record updated | August 13, 2025 |
| Trial ID | NCT07120529 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult, legally competent women with early-stage cervical cancer (FIGO IB1–IIA1, excluding IB3) who had a negative sentinel lymph node biopsy and underwent type B or C radical hysterectomy without a uterine manipulator and with a protective vaginal cuff closure.
✕Probably not a fit
Patients with more advanced disease (FIGO >IIA1 or IB3), positive sentinel nodes, poor performance status (ECOG >2), or those unwilling to undergo required imaging and gynecologic follow-up are unlikely to benefit from the comparisons made here.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a retrospective multicenter study with prospective follow-up comparing long-term survival and perioperative outcomes after radical laparoscopic versus open abdominal hysterectomy performed after the LACC trial. Eligible cases are adult women with FIGO 2018 stages IB1–IIA1 (excluding IB3) and negative sentinel lymph nodes confirmed by ultrastaging. The cohort is restricted to surgeries without a uterine manipulator and with a protective vaginal cuff closure maneuver to limit tumor spill. Primary endpoints are overall survival and progression-free survival, with secondary endpoints including perioperative morbidity and recurrence patterns.
Why it matters
Potential benefit: If successful, the findings could allow eligible patients to receive minimally invasive hysterectomy with confidence that long-term survival and recurrence risk are similar to open surgery.
How similar studies have gone: A large randomized trial (LACC) reported worse outcomes with minimally invasive radical hysterectomy, while later retrospective series that used protective maneuvers have suggested comparable outcomes, so the approach has mixed and not yet definitive evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Women undergoing radical hysterectomy type B or C according to the Querleu-Morrow classification for early-stage cervical cancer (FIGO stages IB1-IIA1, excluding FIGO IB3 between November 2018 and August 2025 Not using manipulator during surgery Vaginal cuff protective maneuver during surgery Conization before surgery (optional) SNB as a first stage of treatment (optional) Exclusion Criteria: Women undergoing surgery for advanced stage cervical cancer (FIGO \>IIA1) or FIGO IB3 Metastasis detected in sentinel node biopsy (confirmed in ultrastaging) ECOG\>2 Not willing to participate in the study Not willing to undergo CT-scans or gynecological examinations
Where it's running
-
Department of Gynaecology, Obstetrics and Gynaecological Oncology, University Clinical Centre, Medical University of Silesia
Katowice, Poland Recruiting -
Oddział Ginekologii Onkologicznej z Pododdziałem Urologii, Opolskie Centrum Onkologii
Opole, Poland Recruiting -
Department of Gynaecological Oncology,
Wroclaw, Poland Recruiting -
Uniwersyteckie Centrum Onkologii, Uniwersytecki Szpital Kliniczny w Białymstoku
Bialystok, Poland Not yet recruiting -
Klinika Ginekologii, Świętokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakład Opieki Zdrowotnej
Kielce, Poland Not yet recruiting
Study contacts
- Study coordinator: Krzysztof Nowosielski, professor
- Email: knowosielski@sum.edu.pl
- Phone: +48 502027943
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cervical screening and care options for women living with HIV who test positive for high-risk HPV
This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.
-
Hydrogel spacer to protect the rectum during cervical cancer radiotherapy
This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.
-
How cinema sessions during chemotherapy might help cervical cancer patients
We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.
-
Predictors of Success and Failure of v-NOTES Hysterectomy for Large Uteri
This study looks at which factors predict whether a v-NOTES hysterectomy for large uteri will be completed without needing to switch to another surgical approach.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.